Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Cytokinetics (CYTK)

Cytokinetics director Santo Costa resigns from board for personal reasons

Neutral Impact 2 of 5 leadership Written later

Cytokinetics said director Santo J. Costa resigned from its Board of Directors with immediate effect, notice given November 1, 2024. The company said the resignation was for personal reasons and not due to any disagreement with the company, and the board was reduced from nine to eight directors.

Key points

  • Santo J. Costa resigned from the Board of Directors effective immediately; notice was given November 1, 2024.
  • The company said the resignation was for personal reasons, not a disagreement on operations, policies, or practices.
  • Board size was reduced from nine to eight directors.
  • The filing was dated November 7, 2024.

The filing

CompanyCytokinetics (CYTK)
Form8-K, current report
Filed with the SECNov 7, 2024, 4:05 PM ET
Accession number0000950170-24-123277

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 07, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.